［1］Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, et al. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile［J］. Infec Immun, 2001, 69 (6):3869-3876.
［2］史瑞明,雷春莲.肺炎支原体感染免疫研究进展［J］. 国外医学·妇幼保健分册, 2002, 13(2):94-96.
［3］Znaor L, Lovri'c S, Hogan Q, Sapunar D. Association of neural inflammation with hyperalgesia following spinal nerve ligation［J］. Croat Med J, 2007, 48(1):35-42.
［4］吴瑞萍,胡亚美,江载芳. 诸福棠实用儿科学［M］. 第6版. 北京: 人民卫生出版社, 1996, 1172-1173.
［5］陈梅, 杜凤兰. 小儿MP感染的实验室检测及其评价［J］. 沈阳部队医药, 2006, 19(1):70.
［6］雷晔飞, 谭金亮, 陈曼平. 肺炎支原体肺炎T细胞亚群免疫球蛋白水平变化的研究［J］. 中国当代儿科杂志, 2005, 7(4):329-330.
［7］Fanslow WC, Anderson DM, Grabstein KH, Clark EA, Cosman D, Armitage RJ. Soluble forms of CD40 inhibit biologic responses of human B cells［J］. J Immunol, 1992, 149(2): 655-660.
［8］刘文彬,王太森,郑淑梅,刘华君,许洪波,郑兴春. 肺炎支原体肺炎免疫功能动态变化［J］.中华微生物学和免疫学杂志, 2004, 24(2)：127.
［9］Morgan BP, Harris CL. Complement therapeutics; history ang current progress［J］. Mol Immunol, 2003, 40(2-4):159-170.
［10］Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, et al. Complex between C1q and C3 or C4: novel and specific markers for classical complement pathway activation［J］.J Immunol Methods, 2005, 298(1-2):35-45.